TAO Synergies Inc. (TAOX) Research

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

Market snapshot

Symbol
TAOX
Price
$3.67
Day change
-4.43%
Market cap
$12.1M
P/E ratio
-1.10x
52-week range
3.25-11.98
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Boundless Bio, Inc. (BOLD)
  • Cadrenal Therapeutics, Inc. Common Stock (CVKD)
  • iBio, Inc. (IBIO)
  • Intensity Therapeutics, Inc. (INTS)
  • Iterum Therapeutics plc (ITRM)
  • Klotho Neurosciences, Inc. (KLTO)
  • NextCure, Inc. (NXTC)
  • Plus Therapeutics, Inc. (PSTV)

Recent insider activity

  • Silverman Joshua — A-Award (200000 shares) on 2026-05-18
  • Bernstein Bruce — A-Award (55000 shares) on 2026-05-18
  • Singer William S. — A-Award (35000 shares) on 2026-05-18
  • WEINSTEIN ROBERT — A-Award (30000 shares) on 2026-05-18
  • Ephron Robert — A-Award (10000 shares) on 2026-05-18

Open TAO Synergies Inc. (TAOX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.